These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37677033)

  • 1. Urokinase-type Plasminogen Activator-induced Mouse Back Pain Model.
    Montera MA; Goins AE; Alles SRA; Westlund KN
    J Vis Exp; 2023 Sep; (199):. PubMed ID: 37677033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator deficiency has little effect on seizure susceptibility and acquired epilepsy phenotype but reduces spontaneous exploration in mice.
    Rantala J; Kemppainen S; Ndode-Ekane XE; Lahtinen L; Bolkvadze T; Gurevicius K; Tanila H; Pitkänen A
    Epilepsy Behav; 2015 Jan; 42():117-28. PubMed ID: 25506794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting urokinase-type plasminogen activator and its receptor for cancer therapy.
    Nozaki S; Endo Y; Nakahara H; Yoshizawa K; Ohara T; Yamamoto E
    Anticancer Drugs; 2006 Nov; 17(10):1109-17. PubMed ID: 17075310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-urokinase-type plasminogen activator is a substrate for hepsin.
    Moran P; Li W; Fan B; Vij R; Eigenbrot C; Kirchhofer D
    J Biol Chem; 2006 Oct; 281(41):30439-46. PubMed ID: 16908524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of the plasminogen/plasmin system.
    Lijnen HR
    Int J Clin Lab Res; 1996; 26(1):1-6. PubMed ID: 8739849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.
    Ellis V; Scully MF; Kakkar VV
    J Biol Chem; 1987 Nov; 262(31):14998-5003. PubMed ID: 3667621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis.
    Glas M; Popp B; Angele B; Koedel U; Chahli C; Schmalix WA; Anneser JM; Pfister HW; Lorenzl S
    Exp Neurol; 2007 Oct; 207(2):350-6. PubMed ID: 17716658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model.
    Das A; Boyd N; Jones TR; Talarico N; McGuire PG
    Arch Ophthalmol; 2004 Dec; 122(12):1844-9. PubMed ID: 15596589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
    Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
    J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.
    Eaton DL; Scott RW; Baker JB
    J Biol Chem; 1984 May; 259(10):6241-7. PubMed ID: 6373753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Dec; 261(36):17120-6. PubMed ID: 3097021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of the protease domain of urokinase-type plasminogen activator.
    Rockway TW; Nienaber V; Giranda VL
    Curr Pharm Des; 2002; 8(28):2541-58. PubMed ID: 12369939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
    Wysocki AB; Kusakabe AO; Chang S; Tuan TL
    Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin.
    Scott RW; Eaton DL; Duran N; Baker JB
    J Biol Chem; 1983 Apr; 258(7):4397-403. PubMed ID: 6339496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection.
    Sanderson-Smith ML; Zhang Y; Ly D; Donahue D; Hollands A; Nizet V; Ranson M; Ploplis VA; Walker MJ; Castellino FJ
    PLoS Pathog; 2013; 9(7):e1003469. PubMed ID: 23853591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
    Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
    J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bicistronic Plasmid Encoding Brain-Derived Neurotrophic Factor and Urokinase Plasminogen Activator Stimulates Peripheral Nerve Regeneration After Injury.
    Karagyaur M; Rostovtseva A; Semina E; Klimovich P; Balabanyan V; Makarevich P; Popov V; Stambolsky D; Tkachuk V
    J Pharmacol Exp Ther; 2020 Mar; 372(3):248-255. PubMed ID: 31888957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
    Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
    J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.